Renhe Pharmacy Co.,Ltd (SHE:000650)

Renhe Pharmacy Co.,Ltd Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Cash & Equivalents	-	2,774	2,329	2,615	2,825	2,360
Short-Term Investments	-	139.21	385.49	155.37	290.03	100
Trading Asset Securities	-	1,093	1,017	764.59	416.87	315.6
Cash & Short-Term Investments	4,106	4,006	3,731	3,534	3,532	2,776
Cash Growth	5.09%	7.37%	5.57%	0.06%	27.25%	-3.83%
Accounts Receivable	-	271.67	466.59	500.18	477.59	539.8
Other Receivables	-	8.92	6.03	8.26	8.82	10.02
Receivables	-	280.59	472.62	508.44	486.41	549.82
Inventory	-	531.11	486.94	446.58	457.74	601.35
Other Current Assets	-	126.4	129.04	94.2	104.33	128.46
Total Current Assets	-	4,944	4,820	4,584	4,581	4,056
Property, Plant & Equipment	-	1,339	1,423	1,250	1,241	1,112
Long-Term Investments	-	602.55	330.91	30.48	536.41	392.69
Goodwill	-	390.89	501.91	546.91	578.24	606.12
Other Intangible Assets	-	293.96	313.44	420.72	582.87	342.74
Long-Term Deferred Tax Assets	-	32.3	32.65	28.25	20.85	6.64
Long-Term Deferred Charges	-	14.29	14.59	16.34	22.93	310.64
Other Long-Term Assets	-	117.89	46.63	568.04	71.9	81.83
Total Assets	-	7,735	7,482	7,445	7,635	6,908

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Accounts Payable	-	170.79	132.08	123.5	199.62	176.08
Accrued Expenses	-	55.23	46.44	33.49	103.52	110.71
Current Portion of Leases	-	0.89	0.69	5.79	6.72	2.84
Current Income Taxes Payable	-	94.24	72.54	209.63	224.76	211.59
Current Unearned Revenue	-	165.47	107.67	124.94	354.56	200.61
Other Current Liabilities	-	276.14	276.93	253.67	275.33	266.84
Total Current Liabilities	-	762.76	636.35	751.01	1,165	968.66
Long-Term Leases	-	1.33	1.89	-	5.79	3.62
Long-Term Unearned Revenue	-	38.93	37.96	37.11	38.83	8.25
Long-Term Deferred Tax Liabilities	-	0.07	0.11	1.88	3.66	0.28
Other Long-Term Liabilities	-	0.18	0.18	0.18	0.18	0.18
Total Liabilities	-	803.26	676.48	790.18	1,213	981

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Common Stock	-	1,400	1,400	1,400	1,400	1,400
Additional Paid-In Capital	-	752.76	796.39	810.81	785.76	766.66
Retained Earnings	-	4,228	4,044	3,842	3,555	3,121
Treasury Stock	-	-64.64	-66.96	-60.08	-	-
Comprehensive Income & Other	-	-0.01	-	-	-	-
Total Common Equity	6,456	6,316	6,174	5,993	5,741	5,287
Minority Interest	-	616.28	632.32	661.46	681	639.65
Shareholders' Equity	7,110	6,932	6,806	6,655	6,422	5,927
Total Liabilities & Equity	-	7,735	7,482	7,445	7,635	6,908

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Total Debt	2.24	2.22	2.58	5.79	12.52	6.46
Net Cash (Debt)	4,104	4,004	3,729	3,529	3,520	2,770
Net Cash Growth	5.10%	7.39%	5.67%	0.25%	27.09%	-1.86%
Net Cash Per Share	2.92	2.85	2.67	2.52	2.51	2.00
Filing Date Shares Outstanding	1,401	1,417	1,307	1,384	1,400	1,400
Total Common Shares Outstanding	1,401	1,417	1,307	1,391	1,400	1,400
Working Capital	-	4,182	4,183	3,833	3,416	3,087
Book Value Per Share	4.61	4.46	4.72	4.31	4.10	3.78
Tangible Book Value	5,775	5,631	5,358	5,025	4,580	4,338
Tangible Book Value Per Share	4.13	3.97	4.10	3.61	3.27	3.10
Buildings	-	1,675	1,516	1,163	1,001	665.33
Machinery	-	575.14	548.17	539.32	549.98	513.22
Construction In Progress	-	53.52	230.72	345.43	409.27	580.58

Data Source: S&P Global Market Intelligence Last updated: Aug 25, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 10, 2026

Data Sources Report a data error